88. Chronic thromboembolic pulmonary hypertension Clinical trials / Disease details

Clinical trials : 159 / Drugs : 118 - (DrugBank : 23) / Drug target genes : 13 - Drug target pathways : 53

17 trials found

diseases per page:

Showing 1 to 10 of 17 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT1041210122	11/01/2021	26/12/2021	Investigational Randomized Controlled Trial of Patients with Chronic Thromboembolic Pulmonary Hypert ...	Investigational Randomized Controlled Trial of Patients with Chronic Thromboembolic Pulmonary Hypert ...	chronic thromboembolic pulmonary hypertension chronic thromboembolic pulmonary hypertension;D006976	Patients will be randomly allocated to riociguattreated group or selexipagtreated group with PVR as ...	Adachi Shiro	NULL	Recruiting	>= 20age old	Not applicable	Both	20	N/A	Japan
2	EUCTR2018-002823-41-AT (EUCTR)	04/10/2019	04/04/2019	A clinical study to assess the efficacy and safety of selexipagas an add-on to standard of care ther ...	A multicenter, randomized, double-blind, placebo-controlled, parallel-group, group-sequential, adapt ...	Chronic Thromboembolic Pulmonary Hypertension, inoperable or persistent/recurrent MedDRA version: 21 ...	Trade Name: Uptravi Product Name: Selexipag Product Code: ACT-293987 INN or Proposed INN: SELEXIPAG	Actelion Pharmaceuticals Ltd	NULL	Not Recruiting			Female: yes Male: yes	280	Phase 3	United States;Portugal;Taiwan;Estonia;Hong Kong;Slovakia;Greece;Thailand;Spain;Ukraine;Russian Feder ...
3	EUCTR2018-002823-41-BG (EUCTR)	17/07/2019	19/04/2019	A clinical study to assess the efficacy and safety of selexipagas an add-on to standard of care ther ...	A multicenter, randomized, double-blind, placebo-controlled, parallel-group, group-sequential, adapt ...	Chronic Thromboembolic Pulmonary Hypertension, inoperable or persistent/recurrent MedDRA version: 21 ...	Trade Name: Uptravi Product Name: Selexipag Product Code: ACT-293987 INN or Proposed INN: SELEXIPAG	Actelion Pharmaceuticals Ltd	NULL	Not Recruiting			Female: yes Male: yes	280	Phase 3	United States;Portugal;Estonia;Taiwan;Hong Kong;Slovakia;Greece;Thailand;Spain;Ukraine;Israel;Russia ...
4	EUCTR2018-002823-41-DK (EUCTR)	15/07/2019	26/04/2019	A clinical study to assess the efficacy and safety of selexipagas an add-on to standard of care ther ...	A multicenter, randomized, double-blind, placebo-controlled, parallel-group, group-sequential, adapt ...	Chronic Thromboembolic Pulmonary Hypertension, inoperable or persistent/recurrent MedDRA version: 21 ...	Trade Name: Uptravi Product Name: Selexipag Product Code: ACT-293987 INN or Proposed INN: SELEXIPAG	Actelion Pharmaceuticals Ltd	NULL	Not Recruiting			Female: yes Male: yes	280	Phase 3	Portugal;United States;Taiwan;Slovakia;Spain;Thailand;Ukraine;Russian Federation;Israel;Switzerland; ...
5	EUCTR2018-002823-41-IT (EUCTR)	03/07/2019	14/06/2021	A clinical study to assess the efficacy and safety of selexipagas an add-on to standard of care ther ...	A multicenter, randomized, double-blind, placebo-controlled, parallelgroup,group-sequential, adaptiv ...	Chronic Thromboembolic Pulmonary Hypertension, inoperable or persistent/recurrent MedDRA version: 21 ...	Trade Name: Uptravi Product Name: SELEXIPAG Product Code: [ACT-293987] INN or Proposed INN: SELEXIPAG	ACTELION PHARMACEUTICALS LTD	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	280	Phase 3	Portugal;United States;Taiwan;Hong Kong;Estonia;Slovakia;Greece;Spain;Thailand;Ukraine;Russian Feder ...
6	EUCTR2018-002823-41-PT (EUCTR)	18/06/2019	30/05/2019	A clinical study to assess the efficacy and safety of selexipagas an add-on to standard of care ther ...	A multicenter, randomized, double-blind, placebo-controlled, parallel-group, group-sequential, adapt ...	Chronic Thromboembolic Pulmonary Hypertension, inoperable or persistent/recurrent MedDRA version: 21 ...	Trade Name: Uptravi Product Name: Selexipag Product Code: ACT-293987 INN or Proposed INN: SELEXIPAG	Actelion Pharmaceuticals Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	280	Phase 3	Portugal;United States;Taiwan;Hong Kong;Estonia;Slovakia;Greece;Spain;Thailand;Ukraine;Russian Feder ...
7	EUCTR2018-002823-41-DE (EUCTR)	03/06/2019	11/09/2018	A clinical study to assess the efficacy and safety of selexipagas an add-on to standard of care ther ...	A multicenter, randomized, double-blind, placebo-controlled, parallel-group, group-sequential, adapt ...	Chronic Thromboembolic Pulmonary Hypertension, inoperable or persistent/recurrent MedDRA version: 21 ...	Trade Name: Uptravi Product Name: Selexipag Product Code: ACT-293987 INN or Proposed INN: SELEXIPAG	Actelion Pharmaceuticals Ltd	NULL	Not Recruiting			Female: yes Male: yes	280	Phase 3	United States;Portugal;Taiwan;Estonia;Hong Kong;Slovakia;Greece;Thailand;Spain;Ukraine;Russian Feder ...
8	EUCTR2018-002823-41-NL (EUCTR)	30/04/2019	20/12/2018	A clinical study to assess the efficacy and safety of selexipagas an add-on to standard of care ther ...	A multicenter, randomized, double-blind, placebo-controlled, parallel-group, group-sequential, adapt ...	Chronic Thromboembolic Pulmonary Hypertension, inoperable or persistent/recurrent MedDRA version: 21 ...	Trade Name: Uptravi Product Name: Selexipag Product Code: ACT-293987 INN or Proposed INN: SELEXIPAG	Actelion Pharmaceuticals Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	280	Phase 3	Mexico;Canada;Argentina;Brazil;Belgium;Poland;Bulgaria;Germany;Sweden;Hungary;Czech Republic;United ...
9	EUCTR2018-002823-41-GB (EUCTR)	25/03/2019	18/09/2018	A clinical study to assess the efficacy and safety of selexipagas an add-onto standard of care thera ...	A multicenter, randomized, double-blind, placebo-controlled, parallelgroup,group-sequential, adaptiv ...	Chronic Thromboembolic Pulmonary Hypertension, inoperable or persistent/recurrent MedDRA version: 21 ...	Trade Name: Uptravi Product Name: Selexipag Product Code: ACT-293987 INN or Proposed INN: SELEXIPAG	Actelion Pharmaceuticals Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	280	Phase 3	United States;Portugal;Taiwan;Estonia;Hong Kong;Slovakia;Greece;Thailand;Spain;Ukraine;Russian Feder ...
10	EUCTR2018-002823-41-BE (EUCTR)	18/03/2019	20/12/2018	A clinical study to assess the efficacy and safety of selexipagas an add-on to standard of care ther ...	A multicenter, randomized, double-blind, placebo-controlled, parallel-group, group-sequential, adapt ...	Chronic Thromboembolic Pulmonary Hypertension, inoperable or persistent/recurrent MedDRA version: 21 ...	Trade Name: Uptravi Product Name: Selexipag Product Code: ACT-293987 INN or Proposed INN: SELEXIPAG	Actelion Pharmaceuticals Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	400	Phase 3	Portugal;United States;Taiwan;Slovakia;Spain;Thailand;Ukraine;Russian Federation;Israel;Switzerland; ...

First Previous1 2Next Last